| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NG0793-227 |
| P8608 | Fatcat ID | release_jlsktj3dxfhknf2776l6iuyhuy |
| P698 | PubMed publication ID | 8395283 |
| P2093 | author name string | N. A. Jenkins | |
| N. G. Copeland | |||
| K. E. Mayo | |||
| W. G. Beamer | |||
| P. Godfrey | |||
| J. O. Rahal | |||
| P2860 | cites work | Receptor-associated resistance to growth hormone-releasing factor in dwarf "little" mice | Q24294956 |
| Mutations in the V2 vasopressin receptor gene are associated with X-linked nephrogenic diabetes insipidus | Q24324030 | ||
| Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa | Q24560214 | ||
| Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1 | Q24563957 | ||
| Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus | Q28183211 | ||
| The pituitary-specific transcription factor GHF-1 is a homeobox-containing protein | Q28283838 | ||
| Etiology of Growth Hormone Deficiency in Little, Ames, and Snell Dwarf Mice* | Q28504445 | ||
| Inherited Ateliotic Dwarfism in Mice: Characteristics of the mutation, little, on Chromosome 6 | Q28507826 | ||
| Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4 | Q28508126 | ||
| Stimulation of growth in the little mouse | Q28513361 | ||
| Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary | Q28576611 | ||
| Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide | Q28578845 | ||
| Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth | Q28594980 | ||
| Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system | Q29614579 | ||
| Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 | Q29617856 | ||
| Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor | Q30449842 | ||
| A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide | Q31035948 | ||
| Expression cloning of an adenylate cyclase-coupled calcitonin receptor | Q33238701 | ||
| Chromosomal location of the octamer transcription factors, Otf-1, Otf-2, and Otf-3, defines multiple Otf-3-related sequences dispersed in the mouse genome | Q33246568 | ||
| Development and applications of a molecular genetic linkage map of the mouse genome | Q33650255 | ||
| Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences | Q34220845 | ||
| Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. | Q34362234 | ||
| Mouse growth-hormone-releasing hormone: precursor structure and expression in brain and placenta | Q35229135 | ||
| Electron microscopic immunocytochemical evidence for the existence of bidirectional synaptic connections between growth hormone-releasing hormone- and somatostatin-containing neurons in the hypothalamus of the rat. | Q35555095 | ||
| A highly conserved mouse gene with a propensity to form pseudogenes in mammals | Q36791686 | ||
| Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus | Q36921900 | ||
| DWARF, A NEW MENDELIAN RECESSIVE CHARACTER OF THE HOUSE MOUSE. | Q37578880 | ||
| Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations | Q39608043 | ||
| Interaction of growth hormone-releasing hormone with the insulin-like growth-factors during prenatal development in the rat. | Q41130271 | ||
| Expression cloning and signaling properties of the rat glucagon receptor | Q41566147 | ||
| Pituitary adenomas in mice transgenic for growth hormone-releasing hormone | Q41595734 | ||
| Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function | Q42452390 | ||
| Expression and localization of growth hormone-releasing hormone messenger ribonucleic acid in rat placenta: in vitro secretion and regulation of its peptide product | Q42477719 | ||
| Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant | Q44768920 | ||
| CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases | Q45137410 | ||
| Partial correction of murine hereditary growth disorder by germ-line incorporation of a new gene | Q45862925 | ||
| Regulation of the pituitary-specific homeobox gene GHF1 by cell-autonomous and environmental cues. | Q45948325 | ||
| Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. | Q46317908 | ||
| A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype | Q46821977 | ||
| Isolated deficiency of immunocytochemically detected somatostatin in Snell dwarf, but not in "little," mice | Q48190598 | ||
| Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour | Q48872563 | ||
| Ontogeny and pituitary regulation of testicular growth hormone-releasing hormone-like messenger ribonucleic acid | Q48908659 | ||
| Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone | Q56850896 | ||
| Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone | Q56850898 | ||
| Dramatic Pituitary Hyperplasia in Transgenic Mice Expressing a Human Growth Hormone-Releasing Factor Gene | Q56911463 | ||
| A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa | Q67482922 | ||
| Cellular Localization and Hormonal Regulation of Follicle-Stimulating Hormone and Luteinizing Hormone Receptor Messenger RNAs in the Rat Ovary | Q67708823 | ||
| Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation | Q68483091 | ||
| Immunoreactive growth hormone-releasing hormone in rat placenta | Q69921220 | ||
| Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly | Q71621977 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Growth hormone releasing hormone receptor | Q15318754 |
| Growth hormone releasing hormone | Q21988130 | ||
| P304 | page(s) | 227–232 | |
| P577 | publication date | 1993-07-01 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function | |
| P478 | volume | 4 |
| Q47279821 | A 5'UTR SNP of GHRHR locus is associated with body weight and average daily gain in Chinese cattle |
| Q70803388 | A little lesson in growth regulation |
| Q48586877 | A new mutation in the growth hormone-releasing hormone receptor gene in two Israeli Arab families |
| Q30476716 | A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis |
| Q35258844 | Advances in endocrinology |
| Q48382552 | Alterations in EEG activity and sleep after influenza viral infection in GHRH receptor-deficient mice |
| Q48509337 | Alterations in GHRH binding and GHRH receptor mRNA in the pituitary of adult dw/dw rats |
| Q33809704 | Alterations in xenobiotic metabolism in the long-lived Little mice |
| Q41702040 | Altered midline axon pathways and ectopic neurons in the developing hypothalamus of netrin-1- and DCC-deficient mice |
| Q28586269 | An essential role for the hematopoietic transcription factor Ikaros in hypothalamic-pituitary-mediated somatic growth |
| Q92924475 | Analysis of Candidate Genes for Growth and Milk Performance Traits in the Egyptian Barki Sheep |
| Q28508001 | Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia |
| Q42150336 | Aortic impedance in Little mice |
| Q33701410 | Applications of new genetic approaches to growth hormone-releasing hormone receptor defects |
| Q45185200 | Aspartic acid scanning mutation analysis of a goldfish growth hormone-releasing hormone (GHRH) receptor specific to the GHRHsalmon-like peptide. |
| Q57632741 | Bases Genéticas dos Distúrbios de Crescimento |
| Q35835950 | Body Composition QTLs Identified in Intercross Populations Are Reproducible in Consomic Mouse Strains |
| Q27332330 | Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism |
| Q37407734 | Cardiac function in young and old Little mice |
| Q48249083 | Cell differentiation. The road not taken |
| Q24319181 | Celsr1, a neural-specific gene encoding an unusual seven-pass transmembrane receptor, maps to mouse chromosome 15 and human chromosome 22qter |
| Q38316688 | Central dopamine D2 receptors regulate growth-hormone-dependent body growth and pheromone signaling to conspecific males. |
| Q73640186 | Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities |
| Q34384700 | Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. Evidence for dual coupling to adenylate cyclase and phospholipase C. |
| Q50531067 | Continuous on-line monitoring of secretion from rodent pituitary endocrine cells using fluorescent protein surrogate markers. |
| Q28303314 | Critical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptors |
| Q34997016 | Current approaches for deciphering the molecular basis of combined anterior pituitary hormone deficiency in humans |
| Q35153827 | DNA damage and ageing: new-age ideas for an age-old problem |
| Q30445850 | Deafness and permanently reduced potassium channel gene expression and function in hypothyroid Pit1dw mutants. |
| Q41681927 | Detecting signatures of selection in nine distinct lines of broiler chickens |
| Q35210750 | Development of neuroendocrine lineages requires the bHLH-PAS transcription factor SIM1. |
| Q51553365 | Differential response to dietary fat in large (LG/J) and small (SM/J) inbred mouse strains. |
| Q37726400 | Diseases associated with growth hormone-releasing hormone receptor (GHRHR) mutations |
| Q78022540 | Does growth hormone prevent or accelerate aging? |
| Q35904811 | Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons |
| Q99614370 | Effect of growth hormone on insulin signaling |
| Q48065435 | Effects of genetic variability of the dairy goat growth hormone releasing hormone receptor (GHRHR) gene on growth traits |
| Q35185668 | Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model |
| Q46920351 | Effects of lactogen resistance and GH deficiency on mouse metabolism: pancreatic hormones, adipocytokines, and expression of adiponectin and insulin receptors |
| Q41727234 | Endocrine effects of IGF-I on normal and transformed breast epithelial cells: potential relevance to strategies for breast cancer treatment and prevention |
| Q36964894 | Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women |
| Q34074037 | Evidence that sensitivity to growth hormone (GH) is growth period and tissue type dependent: studies in GH-deficient lit/lit mice |
| Q37417464 | Exploration of the endogenous agonist mechanism for activation of secretin and VPAC1 receptors using synthetic glycosylated peptides |
| Q36053004 | Extrapituitary effects of the growth hormone-releasing hormone. |
| Q35805031 | Familial Growth Hormone Deficiency and Mutations in the GHRH Receptor Gene |
| Q37353652 | Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice |
| Q37324197 | Fine mapping of "mini-muscle," a recessive mutation causing reduced hindlimb muscle mass in mice |
| Q48641262 | Gene expression profiling during cellular differentiation in the embryonic pituitary gland using cDNA microarrays. |
| Q33301487 | Gene expression profiling of long-lived dwarf mice: longevity-associated genes and relationships with diet, gender and aging |
| Q34624434 | Genetic background determines if Stat5b suppresses or enhances murine hepatocarcinogenesis |
| Q33838238 | Genetic defects of the growth hormone-insulin-like growth factor axis |
| Q34716062 | Genetic disorders of human growth |
| Q33975032 | Genetic regulation of the embryology of the pituitary gland and somatotrophs |
| Q49416326 | Genetical genomics of growth in a chicken model |
| Q34056811 | Genetically caused retarded growth in animals |
| Q34158378 | Growth Hormone Releasing Hormone (GHRH) and the GHRH Receptor. |
| Q63412752 | Growth Hormone-Releasing Hormone: Discovery, Regulation, and Actions |
| Q38631149 | Growth factor, energy and nutrient sensing signalling pathways in metabolic ageing. |
| Q35668780 | Growth hormone and IGF-1. |
| Q36578881 | Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites |
| Q35813450 | Growth hormone response to growth hormone-releasing peptide-2 in growth hormone-deficient little mice |
| Q35185769 | Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists |
| Q34774490 | Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis |
| Q28390350 | Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice |
| Q30445064 | Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors |
| Q34181179 | Growth hormone-releasing hormone: not only a neurohormone. |
| Q28506940 | Gsh-1, an orphan Hox gene, is required for normal pituitary development |
| Q37378418 | Hepatic-specific accessibility of Igf1 gene enhancers is independent of growth hormone signaling |
| Q46990759 | Hormonal regulation of hepatic multidrug resistance-associated protein 2 (Abcc2) primarily involves the pattern of growth hormone secretion |
| Q26822806 | Human conditions of insulin-like growth factor-I (IGF-I) deficiency |
| Q71985633 | Human growth hormone-releasing hormone receptor (GHRHR) maps to a YAC at chromosome 7p15 |
| Q39650181 | Human prostate cancer xenografts in lit/lit mice exhibit reduced growth and androgen‐independent progression |
| Q73109427 | Hyaluronan synthesis by epiphysial chondrocytes is regulated by growth hormone, insulin-like growth factor-1, parathyroid hormone and transforming growth factor-beta 1 |
| Q35229825 | IGF-1 and bone: New discoveries from mouse models |
| Q34889024 | IGF-I, GH, and sex steroid effects in normal mammary gland development |
| Q28594618 | Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice |
| Q42488151 | Increased hypothalamic somatostatin expression in mice transgenic for bovine or human GH. |
| Q36710162 | Insights into the structural basis of endogenous agonist activation of family B G protein-coupled receptors |
| Q34074077 | Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms |
| Q30307314 | Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2. |
| Q43622804 | Isolated growth hormone (GH) deficiency due to compound heterozygosity for two new mutations in the GH-releasing hormone receptor gene |
| Q33777892 | Knock your SOCS off! |
| Q34552549 | Life extension in the dwarf mouse |
| Q33997388 | Mammary gland development and tumorigenesis in estrogen receptor knockout mice |
| Q73909345 | Mapping of the grt locus to mouse chromosome 5 |
| Q30440919 | Matrix metalloproteinase-28 deletion amplifies inflammatory and extracellular matrix responses to cardiac aging |
| Q37670847 | Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span |
| Q30442420 | Model-projected mechanistic bases for sex differences in growth hormone regulation in humans |
| Q30304178 | Molecular and cell biology of the growth hormone-releasing hormone receptor |
| Q24604062 | Molecular basis for negative regulation of the glucagon receptor |
| Q40502069 | Molecular biology of the growth hormone-prolactin gene system |
| Q36872219 | Molecular physiology of pituitary development: signaling and transcriptional networks |
| Q48090940 | Molecular, morphometric and functional analyses demonstrate that the growth hormone deficient little mouse is not hypomyelinated |
| Q30434197 | Muscle mechano growth factor is preferentially induced by growth hormone in growth hormone-deficient lit/lit mice |
| Q33767023 | Mutations in the growth hormone releasing hormone receptor: a new form of dwarfism in humans |
| Q37001127 | Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis |
| Q41081328 | New insights into the regulation of somatotrope function using genetic and transgenic models |
| Q24311677 | Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse |
| Q30435984 | Novel relationships of age, visceral adiposity, insulin-like growth factor (IGF)-I and IGF binding protein concentrations to growth hormone (GH) releasing-hormone and GH releasing-peptide efficacies in men during experimental hypogonadal clamp |
| Q28295495 | Opposing LSD1 complexes function in developmental gene activation and repression programmes |
| Q24621746 | P-OTX: a PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development |
| Q43143999 | Peanuts can contribute to anaphylactic shock by activating complement. |
| Q38292573 | Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain |
| Q44505357 | Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism |
| Q92394724 | Plausible Links Between Metabolic Networks, Stem Cells, and Longevity |
| Q53977209 | Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. |
| Q30433639 | Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice |
| Q36734567 | Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models. |
| Q54376076 | Role of Ras, ERK, and Akt in glucocorticoid-induced differentiation of embryonic rat somatotropes in vitro. |
| Q37108121 | Role of insulin and growth hormone/insulin-like growth factor-I signaling in lifespan extension: rodent longevity models for studying aging and calorie restriction |
| Q24645123 | Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. |
| Q28508170 | SOCS2 negatively regulates growth hormone action in vitro and in vivo |
| Q28260872 | Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors |
| Q44185826 | Sleep in mice with nonfunctional growth hormone-releasing hormone receptors |
| Q40858441 | Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone |
| Q46290690 | Strain differences in bone density and calcium metabolism between C3H/HeJ and C57BL/6J mice |
| Q29616716 | Structural diversity of G protein-coupled receptors and significance for drug discovery |
| Q33861093 | Structure and function of the growth-hormone-releasing hormone receptor |
| Q89621690 | Studies on the Small Body Size Mouse Developed by Mutagen N-Ethyl-N-nitrosourea |
| Q28710413 | The Developmental Basis of Quantitative Craniofacial Variation in Humans and Mice |
| Q33817029 | The GH/IGF-1 axis in ageing and longevity |
| Q37247877 | The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration |
| Q34254203 | The growth hormone-releasing hormone receptor |
| Q41239137 | The hypothalamic-pituitary axis: co-development of two organs |
| Q50978263 | The influence of growth hormone/insulin-like growth factor deficiency on prostatic dysplasia in pbARR2-Cre, PTEN knockout mice. |
| Q40422397 | The molecular pathology of pituitary hormone deficiency and resistance |
| Q34988259 | The pathogenesis of pituitary tumours |
| Q41175213 | The regulation of growth hormone secretion |
| Q34888096 | The role of endocrine insulin-like growth factor-I and insulin in breast cancer |
| Q28088532 | The somatotropic axis and longevity in mice |
| Q48913893 | Tissue-specific molecular heterogeneity of human growth hormone-releasing hormone receptor protein |
| Q40712362 | Transcript abundance in mouse pituitaries with altered growth hormone expression quantified by reverse transcriptase polymerase chain reaction implicates transcription factor Zn-16 in gene regulation in vivo |
| Q34460402 | Transcription factors in pituitary development |
| Q38351359 | Two ENU-induced mutations in Rasgrf1 and early mouse growth retardation. |
| Q32053503 | Upregulation of human chorionic gonadotrophin-induced steroidogenic acute regulatory protein by insulin-like growth factor-I in rat Leydig cells |
| Q34399090 | Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation |
| Q33684553 | Young little mice express a premature cardiovascular aging phenotype |
| Q74031022 | [Molecular pathology of the GHRH receptor] |
Search more.